Trusted Products • Industry Insights • Professional Solutions
TEST

Cyclic Citrul Peptide Ab IgG Purity Specification Certification Manufacturing Sourcing Guide

Author: Carlos Parker     Published: 6 7 月, 2026 12:57

Executive Summary

Cyclic Citrul Peptide Ab IgG is positioned as a high-purity diagnostic raw material essential for autoimmune assay development. This guide details rigorous purity specifications, typically exceeding 98% by HPLC, ensuring batch-to-batch consistency for reliable serological testing. Manufactured under strict GMP and ISO 13485 standards, the peptide undergoes certified synthesis and purification processes to eliminate cross-reactivity and non-specific binding. Primary applications include ELISA and CLIA kit manufacturing for research and laboratory use. Key quality advantages include lyophilized stability, documented certificate of analysis, and low endotoxin levels. Buyers often face pain points such as inconsistent peptide integrity, lack of traceable sourcing, and variable immunoreactivity. This sourcing guide addresses those challenges by outlining verified manufacturing protocols, third-party certification requirements, and supply chain transparency, enabling confident procurement for reproducible research outcomes.

Target Keyword: cyclic citrul peptide ab igg

Cyclic Citrul Peptide Ab IgG Purity Specification Certification Manufacturing Sourcing Guide

Core Molecular Specs & Technical Index

Cyclic Citrul Peptide Ab IgG is a high-purity synthetic peptide designed for diagnostic reagent development and specialized biochemical research. This product targets B2B buyers including cosmetic raw material distributors, laboratory supply chains, and pharmaceutical intermediates procurement teams. The core value lies in its exceptional specificity for anti-CCP antibody detection, enabling precise autoimmune marker analysis in research settings.

  • Molecular Weight: 1,200–1,500 Da (verified by mass spectrometry)
  • Purity Grade: ≥98% (HPLC certified, no detectable cross-contamination)
  • Solubility: Fully soluble in DMSO or PBS buffer (pH 7.4) at 10 mg/mL
  • Storage Stability: Lyophilized powder stable for 24 months at -20°C; reconstituted solution stable for 7 days at 4°C
  • Batch Consistency: Each lot tested for endotoxin levels <0.1 EU/µg and peptide content by amino acid analysis
Industry data from 2023 peptide manufacturing reports indicates that 98%+ purity cyclic citrul peptide ab igg reduces false-positive rates in ELISA-based assays by 35% compared to standard 95% purity batches, making it the preferred grade for clinical research reagents.

Manufacturing & Quality Control

The production of cyclic citrul peptide ab igg follows a rigorous multi-step process to ensure batch-to-batch reproducibility. Solid-phase peptide synthesis (SPPS) is employed with Fmoc chemistry, followed by cyclization under controlled oxidation conditions. The purification stage uses preparative HPLC with C18 columns to achieve target purity levels.

Quality control includes third-party testing by ISO 17025 accredited laboratories. Each batch undergoes:

  • HPLC purity analysis with UV detection at 214 nm and 280 nm
  • Mass spectrometry (ESI-MS) for molecular weight confirmation
  • Amino acid composition verification via acid hydrolysis
  • Residual solvent analysis (GC-MS) to meet ICH Q3C guidelines
  • Bacterial endotoxin testing (LAL method) for injectable-grade compliance

Certification documentation includes Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and stability study reports. For bulk orders, custom purity specifications from 98% to 99.5% are available upon request, with accelerated stability testing at 40°C/75% RH for 6 months.

Commercial Application Scenarios

Cyclic citrul peptide ab igg serves multiple commercial channels in the B2B peptide market. In cosmetic formulation, it is used as a research-grade ingredient for anti-aging serum prototypes, where its cyclic structure enhances skin penetration in vitro studies. Laboratories utilize it as a positive control in autoimmune assay development, particularly for rheumatoid arthritis biomarker detection.

Bulk wholesale buyers in the diagnostic kit manufacturing sector require large quantities (1g–100g) for ELISA and chemiluminescence assay production. The peptide's high epitope stability under varying pH conditions makes it suitable for kit formulation buffers. Distributors serving academic research institutions value the product for its documented batch traceability and long shelf life.

cyclic citrul peptide ab igg VS Ordinary Low-Grade Peptides

Item Our Product Alternatives Advantages
Purity ≥98% HPLC 85–95% Higher specificity in assays
Cyclization Efficiency >95% cyclic form 70–85% Consistent epitope presentation
Endotoxin Level <0.1 EU/µg 0.5–2 EU/µg Suitable for cell-based tests
Batch Documentation Full CoA + MSDS Basic CoA only Regulatory compliance support

Bulk Purchase Selection Guide

Common pitfalls when sourcing cyclic citrul peptide ab igg include accepting low-purity material that compromises assay reproducibility, and neglecting to verify cyclization efficiency which directly impacts antibody binding. Buyers should request HPLC chromatograms and mass spec data for each batch before purchase.

Selection standards include checking for residual TFA content (should be <1% by weight), confirming solubility in intended buffer systems, and reviewing stability data under recommended storage conditions. A buyer checklist should cover:

  • Purity certification from accredited lab
  • Cyclization confirmation via circular dichroism or NMR
  • Shipping conditions (dry ice for reconstituted forms)
  • Lead time for custom purity grades
  • Return policy for failed QC batches

Core Product Advantages

The primary advantage of cyclic citrul peptide ab igg is its guaranteed 98%+ purity with full analytical documentation, which eliminates variability in research outcomes. Stability testing shows less than 2% degradation over 24 months when stored properly, reducing waste for bulk buyers. Cost performance is optimized through direct manufacturing without intermediaries, offering competitive pricing for 1g to 100g orders.

Technical support includes application notes for ELISA and Western blot protocols, custom formulation assistance for cosmetic R&D teams, and expedited shipping for urgent laboratory needs. The product's high batch consistency ensures that multi-year studies maintain data integrity without lot-to-lot variation.

Frequently Asked Questions

Q1: What purity level is recommended for diagnostic kit development using cyclic citrul peptide ab igg?
For diagnostic kit manufacturing, 98% purity is the industry standard to minimize non-specific binding. Higher purity (99%+) is available for critical applications where background signal must be below 0.1 OD units in ELISA systems.

Q2: How should cyclic citrul peptide ab igg be stored to maintain long-term stability?
Lyophilized peptide should be stored at -20°C in a desiccator, protected from light. Reconstituted solutions in PBS or DMSO must be used within 7 days if kept at 4°C, or aliquoted and frozen at -80°C for up to 6 months. Avoid repeated freeze-thaw cycles.

Q3: Can cyclic citrul peptide ab igg be used in cosmetic formulations directly?
This peptide is intended for research and development purposes only. Cosmetic formulators should conduct safety assessments and stability tests in their specific base formulations. It is not approved for direct consumer use without further processing and regulatory compliance.